• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性和无症状性颅内动脉粥样硬化性狭窄:3 年前瞻性研究。

Symptomatic and asymptomatic intracranial atherosclerotic stenosis: 3 years' prospective study.

机构信息

Department of Neurology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.

Institute of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.

出版信息

J Neurol. 2020 Jun;267(6):1687-1698. doi: 10.1007/s00415-020-09750-2. Epub 2020 Feb 25.

DOI:10.1007/s00415-020-09750-2
PMID:32100122
Abstract

BACKGROUND

Intracranial stenoses can cause TIA/ischaemic stroke. The purpose of this study was to assess vascular risk factors, clinical and imaging findings and outcome in Caucasians with intracranial stenosis under best prevention management.

METHODS

In this prospective observational study (from 05/2012, to last follow-up 06/2017) we compared vascular risk factors, imaging findings and long-term outcome in Swiss patients with symptomatic versus asymptomatic intracranial atherosclerotic stenoses on best prevention management.

RESULTS

62 patients were included [35.5% women, median age 68.3 years], 33 (53.2%) with symptomatic intracranial stenoses. Vascular risk factors (p = 0.635) and frequency of anterior circulation stenoses (66.7% vs. 55.2%; p = 0.354) did not differ between symptomatic and asymptomatic patients, but CT/MR-perfusion deficits in the territory of the stenosis (81.8% vs. 51.7%; p = 0.011) were more common in symptomatic patients. Outcome in symptomatic and asymptomatic patients at last follow-up was similar (mRS 0-1:66.7% vs. 75%;p = 0.937, mRS p-shift = 0.354, survival:100% vs. 96.4%;p = 0.979). However, during 59,417 patient follow-up days, symptomatic patients experienced more cerebrovascular events (ischaemic stroke or TIA) [37.5% vs. 7.1%;HR 7.58;p = 0.012], mainly in the territory of the stenosis [31.3% vs. 3.6%;HR 12.69;p = 0.019], more vascular events (i.e. ischaemic stroke/TIA/TNA and acute coronary/peripheral vascular events) [62.5% vs. 14.3%;HR 6.37;p = 0.001]) and more multiple vascular events (p-trend = 0.006; ≥ 2:37.5% vs. 10.7%; OR 5.37;p = 0.022) than asymptomatic patients.

CONCLUSIONS

Despite best prevention management, one in three patients with a symptomatic intracranial stenosis suffered a cerebrovascular event, three in five a vascular event and two in five ≥ 2 vascular events. There is an unmet need for more rigorous and effective preventive strategies in patients with symptomatic intracranial stenoses.

摘要

背景

颅内狭窄可导致 TIA/缺血性中风。本研究旨在评估在最佳预防管理下,白种人群颅内狭窄患者的血管危险因素、临床和影像学表现及预后。

方法

在这项前瞻性观察研究(2012 年 5 月至 2017 年 6 月最后一次随访)中,我们比较了瑞士患者在最佳预防管理下有症状和无症状颅内动脉粥样硬化性狭窄的血管危险因素、影像学表现和长期预后。

结果

共纳入 62 例患者[35.5%为女性,中位年龄 68.3 岁],33 例(53.2%)为有症状颅内狭窄。有症状和无症状患者的血管危险因素(p=0.635)和前循环狭窄的频率(66.7%与 55.2%;p=0.354)无差异,但狭窄区域的 CT/MR 灌注缺损(81.8%与 51.7%;p=0.011)在有症状患者中更常见。有症状和无症状患者在最后一次随访时的预后相似(mRS 0-1:66.7%与 75%;p=0.937,mRS 差值 p=0.354,生存率:100%与 96.4%;p=0.979)。然而,在 59417 患者随访日中,有症状患者发生更多的脑血管事件(缺血性中风或 TIA)[37.5%与 7.1%;HR 7.58;p=0.012],主要发生在狭窄区域[31.3%与 3.6%;HR 12.69;p=0.019],更多血管事件(即缺血性中风/TIA/TNA 和急性冠状动脉/外周血管事件)[62.5%与 14.3%;HR 6.37;p=0.001]和更多多次血管事件(p 趋势=0.006;≥2 次:37.5%与 10.7%;OR 5.37;p=0.022)比无症状患者更常见。

结论

尽管进行了最佳预防管理,仍有三分之一的有症状颅内狭窄患者发生脑血管事件,五分之三的患者发生血管事件,五分之二的患者发生≥2 次血管事件。有症状颅内狭窄患者需要更严格和有效的预防策略。

相似文献

1
Symptomatic and asymptomatic intracranial atherosclerotic stenosis: 3 years' prospective study.症状性和无症状性颅内动脉粥样硬化性狭窄:3 年前瞻性研究。
J Neurol. 2020 Jun;267(6):1687-1698. doi: 10.1007/s00415-020-09750-2. Epub 2020 Feb 25.
2
Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.短暂性脑缺血发作或小卒中患者症状性颅内狭窄的患病率、预测因素和预后:一项基于人群的队列研究。
Lancet Neurol. 2020 May;19(5):413-421. doi: 10.1016/S1474-4422(20)30079-X.
3
Prognosis of Asymptomatic Intracranial Stenosis in Patients With Transient Ischemic Attack and Minor Stroke.无症状性颅内狭窄患者短暂性脑缺血发作和小卒中的预后。
JAMA Neurol. 2020 Aug 1;77(8):947-954. doi: 10.1001/jamaneurol.2020.1326.
4
Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study.颅内动脉粥样硬化性梗死复发:来自 MyRIAD 研究的结果。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
5
Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis.有症状颅内动脉狭窄个体短暂性脑缺血发作后的早期卒中风险
Arch Neurol. 2008 Jun;65(6):733-7. doi: 10.1001/archneur.65.6.733.
6
Long-term recurrence of ischemic events in patients with intracranial atherosclerotic stenosis stratified by symptoms and pathogenesis.颅内动脉粥样硬化狭窄患者按症状和发病机制分层的缺血性事件长期复发。
J Neurol Sci. 2024 Jan 15;456:122838. doi: 10.1016/j.jns.2023.122838. Epub 2023 Dec 13.
7
The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.巴塞罗那无症状颅内动脉粥样硬化研究:亚临床颅内动脉粥样硬化作为长期血管事件的预测指标。
Atherosclerosis. 2019 Mar;282:132-136. doi: 10.1016/j.atherosclerosis.2019.01.022. Epub 2019 Jan 29.
8
Recurrence in intracranial atherosclerotic disease: a stenosis-based analysis.颅内动脉粥样硬化性疾病的复发:基于狭窄的分析
J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2080-2084. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.015. Epub 2014 Aug 8.
9
Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome.因短暂性缺血性神经功能缺损或中风发作而出现症状的大脑中动脉狭窄的选择性支架置入术:短期血管造影和临床结果
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):847-51. doi: 10.1136/jnnp.2003.019570.
10
Association of distal hyperintense vessel sign and recurrent stroke in patients with symptomatic intracranial stenosis.症状性颅内狭窄患者的远端高信号血管征与复发性卒中的相关性。
J Stroke Cerebrovasc Dis. 2022 Sep;31(9):106616. doi: 10.1016/j.jstrokecerebrovasdis.2022.106616. Epub 2022 Jul 9.

引用本文的文献

1
A bibliometric and visualized analysis of interventional treatment for intracranial atherosclerotic stenosis (from 2004 to 2023).颅内动脉粥样硬化狭窄介入治疗的文献计量学与可视化分析(2004年至2023年)
Neurosurg Rev. 2025 Mar 22;48(1):315. doi: 10.1007/s10143-025-03473-6.
2
Lipid on stroke in intracranial artery atherosclerotic stenosis: a mediation role of glucose.颅内动脉粥样硬化性狭窄患者的血脂与卒中:血糖的中介作用。
Front Endocrinol (Lausanne). 2024 Aug 20;15:1322114. doi: 10.3389/fendo.2024.1322114. eCollection 2024.
3
Brain frailty associated with stroke events in anterior circulation large artery occlusion.

本文引用的文献

1
Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.支架置入治疗有症状性椎动脉狭窄:一项预先计划的个体化患者数据汇总分析。
Lancet Neurol. 2019 Jul;18(7):666-673. doi: 10.1016/S1474-4422(19)30149-8. Epub 2019 May 23.
2
The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.巴塞罗那无症状颅内动脉粥样硬化研究:亚临床颅内动脉粥样硬化作为长期血管事件的预测指标。
Atherosclerosis. 2019 Mar;282:132-136. doi: 10.1016/j.atherosclerosis.2019.01.022. Epub 2019 Jan 29.
3
Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds.
大脑脆弱与前循环大动脉闭塞性中风事件有关。
BMC Neurol. 2024 Mar 18;24(1):97. doi: 10.1186/s12883-024-03566-7.
4
A systematic review and meta-analysis of Comaneci/Cascade temporary neck bridging devices for the treatment of intracranial aneurysms.对用于治疗颅内动脉瘤的科马内奇/卡斯卡德临时颈部搭桥装置的系统评价和荟萃分析。
Front Hum Neurosci. 2023 Sep 25;17:1276681. doi: 10.3389/fnhum.2023.1276681. eCollection 2023.
5
A rare case of recurrent headache during exercise due to severe intracranial atherosclerotic stenosis.一例罕见的因严重颅内动脉粥样硬化狭窄导致运动时反复头痛的病例。
J Neurosci Rural Pract. 2022 Oct-Dec;13(4):775-777. doi: 10.25259/JNRP-2022-5-2. Epub 2022 Oct 22.
6
MRA-detected intracranial atherosclerotic disease in patients with TIA and minor stroke.磁共振血管成像检测短暂性脑缺血发作和小卒中患者的颅内动脉粥样硬化性疾病。
Ir J Med Sci. 2023 Jun;192(3):1395-1399. doi: 10.1007/s11845-022-03094-8. Epub 2022 Jul 15.
7
Intracranial Arterial Calcification Relates to Long-Term Risk of Recurrent Stroke and Post-stroke Mortality.颅内动脉钙化与复发性中风的长期风险及中风后死亡率相关。
Front Neurol. 2020 Oct 9;11:559158. doi: 10.3389/fneur.2020.559158. eCollection 2020.
8
Intracranial Vertebrobasilar Calcification in Patients with Ischemic Stroke is a Predictor of Recurrent Stroke, Vascular Disease, and Death: A Case-Control Study.颅内椎基底动脉钙化在缺血性脑卒中患者中是复发性卒中、血管疾病和死亡的预测因子:一项病例对照研究。
Int J Environ Res Public Health. 2020 Mar 18;17(6):2013. doi: 10.3390/ijerph17062013.
多动脉床中短暂性脑缺血发作或脑卒中伴症状性血管疾病患者的长期预后。
Stroke. 2018 Jul;49(7):1639-1646. doi: 10.1161/STROKEAHA.118.020913. Epub 2018 Jun 7.
4
Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis.机械取栓术及挽救治疗伴粥样硬化的颅内大动脉闭塞。
J Neurointerv Surg. 2018 Aug;10(8):746-750. doi: 10.1136/neurintsurg-2017-013489. Epub 2017 Dec 4.
5
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.载脂蛋白 AI 模拟肽(Anacetrapib)在动脉粥样硬化性血管疾病患者中的作用。
N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28.
6
Transluminal angioplasty and stenting versus conservative treatment in patients with symptomatic basilar artery stenosis : Perspective for future clinical trials.症状性基底动脉狭窄患者的腔内血管成形术和支架置入术与保守治疗的比较:对未来临床试验的展望
Clin Neuroradiol. 2018 Mar;28(1):33-38. doi: 10.1007/s00062-016-0528-x. Epub 2016 Aug 9.
7
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.降压预防心血管疾病和死亡:系统评价和荟萃分析。
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
8
Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.球囊扩张颅内支架与药物治疗对症状性颅内狭窄患者卒中风险的影响:VISSIT 随机临床试验。
JAMA. 2015;313(12):1240-8. doi: 10.1001/jama.2015.1693.
9
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.极低水平的致动脉粥样硬化脂蛋白与心血管事件风险:他汀类药物试验的荟萃分析。
J Am Coll Cardiol. 2014 Aug 5;64(5):485-94. doi: 10.1016/j.jacc.2014.02.615.
10
Intracranial atherosclerosis: current understanding and perspectives.颅内动脉粥样硬化:当前的认识和观点。
J Stroke. 2014 Jan;16(1):27-35. doi: 10.5853/jos.2014.16.1.27. Epub 2014 Jan 31.